Manulife (Manufacturers Life Insurance)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Manulife (Manufacturers Life Insurance)'s XBI Position: Q3 2025 in Review
Manulife (Manufacturers Life Insurance) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 3,130 shares — an estimated $260K sold.
Manulife (Manufacturers Life Insurance) first reported a position in XBI in Q2 2015 and held it in 17 quarters. The position peaked at $6.64M in Q2 2020. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.
- Manulife (Manufacturers Life Insurance) reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 3,130 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $260K.
- Manulife (Manufacturers Life Insurance) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 17 quarters.
- Manulife (Manufacturers Life Insurance)'s State Street SPDR S&P Biotech ETF position peaked at $6.64M in Q2 2020.
- 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.